Median Age (years) | 57.8 | (range 31–80) |
---|---|---|
Median Karnofsky performance index | 70 | (range 40–90) |
Sex | (n) | (percent) |
- Male | 8 | 42.1 |
- Female | 11 | 57.9 |
Treatment technique | (n) | (percent) |
- 2D | 3 | 15.8 |
- HT | 16 | 84.2 |
Treatment Field | (n) | (percent) |
- CSI | 15 | 78.9 |
- SI | 4 | 21.1 |
CNS disease | (n) | (percent) |
- Macroscopic | 18 | 94.7 |
- Microscopic | 1 | 5.3 |
Presence of systemic disease outside of the CNS | (n) | (percent) |
- Yes | 7 | 36.8 |
- No | 11 | 57.9 |
- Not available | 1 | 5.3 |
Primary Diagnosis | ||
- Breast cancer | 5 | 26.3 |
- NSCLC | 5 | 26.3 |
- Non-Hodgkin Lymphoma | 3 | 15.9 |
- Adenocarcinoma of gastro-esophageal junction | 1 | 5.3 |
- Astrocytoma WHO Grade III | 1 | 5.3 |
- Gastric carcinoma | 1 | 5.3 |
- Malignant peripheral nerve sheath tumor | 1 | 5.3 |
- non-CNS NGGCT | 1 | 5.3 |
- Sarcomatoid CUP | 1 | 5.3 |